Dramatically, when the product expired in April and May this year, the other side indicated that it had liquidity problems. In repeated consultations, it was found that Xia Xuewen, the actual controller of Minxing Pharmaceutical Company, had lost contact and was nowhere to be found.
Such dramatic changes have aroused the attention of Central Plains Securities. The chairman of Central Plains Securities personally led a team to report the case to Henan Public Security Bureau. The public security organs immediately filed the case, and Xia Xuewen was also detained by Fuzhou Public Security Bureau.
At the same time, in addition to the Central Plains Securities, Huaxin Trust, including the League of Nations Trust, China Food Trust have fallen into the pit of accounts receivable financing of Minxing Pharmaceutical.
The chairwoman is missing
Lieutenant Jun received a Relevant Notes on Company Management Alliance No. 17 and Zhongjing No. 1, which mainly introduced the risk situation of two management products.
Specifically, the Alliance 17 Asset Management Plan (referred to as Alliance 17), which was founded on December 8, 2017, raised 59.84 million yuan and expired on April 24, 2019.
Founded on February 5, 2018, the Zhongjing 1 Asset Management Plan (abbreviated as Zhongjing 1) raised 182 million yuan, and expired on May 7, 2019. The two capital management products raised a total of 242 million yuan.
Alliance No. 17 and Zhongjing No. 1 are all set up through Huaxin Trusts Huaxin Trust and Xinyuan No. 39 Collective Fund Trust Plan. That is to say, two products wear a vest, Huaxin Trust is the channel, and ultimately invested in Fujian Fujian Minxing Pharmaceutical Co., Ltd. (referred to as Fujian Xing Pharmaceutical) to the Union Medical Hospital affiliated to Fujian Medical University. Accounts receivable, as a financier, Minxing Pharmaceutical Company undertakes the obligation to make up the difference. Xia Xuewen, the actual controller of Xingxing Pharmaceutical Company, provides joint and several liability guarantee.
Through a private third-party Golden Axe inquiry, Xuejun learned that the managers of Alliance No. 17 and Beijing No. 1 were Zhongyuan Securities. The strategies were all other strategies, and the fund type was Securities Business Capital Management.
Until the end of April this year, when the product expired, Zhongyuan Securities had to give an account to investors. So the project manager went thousands of miles to Fuzhou, Fujian Province to communicate about repayment. The financier Minxing Pharmaceutical said that there was liquidity problem, that is, I am short of money.
Central Plains Securities is in a fog. Whats the matter? According to reason, it shouldnt be. In the industry, the accounts receivable of this hospital are very hard. After all, its impossible to hang up the accounts on credit when seeing a doctor. If you dont have money, youll have to give cash to see a doctor. The cash flow of the hospital can be said to be very good. You shouldnt have no money.
As a result, Zhongyuan Securities dispatched special personnel to Fuzhou to investigate the situation, held many rounds of consultations with the financiers, and coordinated Huaxin Trust and other parties to urge Minxing Medicine to pay back the money. In the course of repeated measures, a strange phenomenon was found, and Xia Xuewen, the actual controller of Minxing Medicine, was never seen. Unfortunately, the chairman of Minxing Pharmaceutical Company played with the disappearance.
According to the data, Xia Xuewen holds 96.25% of Minxing Pharmaceutical Company and is the actual controller. Xia Xuewen is also the chairman and CEO of Minxing Pharmaceutical Company.
The chairman of the securities firm reported the case personally
It invested 240 million yuan in management products. The investment was that the accounts receivable of Fujian Medical University Affiliated Union Medical College Hospital was out of order. Xia Xuewen, chairman of Fujian Medical University, also hid.
This situation has aroused the attention of Zhongyuan Securities. The chairman of Zhongyuan Securities immediately led a team to report to Henan Public Security Bureau. After the case was filed by the public security organs, relevant work was carried out. The latest situation is that Xia Xuewen, the actual controller of Minxing Medicine, has been detained by Fuzhou Public Security Bureau.
According to the data, the headquarters of Zhongyuan Securities is located in Zhengzhou, Henan Province. The top five shareholders include Henan Investment Group, Bohai Industrial Investment Fund - Phase I of Bohai Industrial Investment Fund, Anyang Iron and Steel Group, China Pingmei Shenma Energy, etc.
Lieutenant Jun noticed that besides the Central Plains Securities and Channel Fang Huaxin Trust, the League of Nations Trust and COFCO Trust were involved.
Tian Eye Check shows that the League of Nations Trust in Jiangsu has also been involved, involving 360 million yuan in funds.
It is understood that the League of Nations Trust submitted an application for property preservation before litigation to the Wuxi Intermediate Court on May 13, 2019, requesting the freezing of 360 million yuan of deposits in Fujian Medical University Affiliated Union Hospital and Fujian Xing Medical Deposit, or the seizure and seizure of other equivalent property, and provided a clue to freezing property, including Fujian Xing Medical Deposit to Fujian Province. The creditors rights of receivables, such as Union Medical College Hospital affiliated to Medical University, Fujian Cancer Hospital, Fujian Provincial Hospital and First Hospital affiliated to Fujian Medical University, were frozen for three years, involving 360 million yuan in the preservation of the subject matter.
According to public data, China Food Trust has also established the Minxing Medical Receivables Collective Fund Trust Scheme, which was established on April 11, 2017 with an expected return of 6.5%. Source: Yang Bin_NF4368
According to public data, China Food Trust has also established the Minxing Medical Receivables Collective Fund Trust Scheme, which was established on April 11, 2017 with an expected return of 6.5%.